Hydreight Technologies Inc. (TSXV: NURS; OTCQB: HYDTF; FSE: SO6), a rapidly expanding mobile clinical network providing at-home healthcare services across all 50 U.S. states, announced today the launch of new oral weight loss therapies on its VSDHOne telehealth platform. These therapies are offered in three convenient forms: sublingual drops, capsules, and tablets.
The move further solidifies Hydreight’s leadership in the telehealth sector while positioning the company to capitalize on the growing global weight loss market.
Expanding Access to Weight Loss Solutions Nationwide
The newly introduced treatments provide a range of flexible, needle-free options for individuals seeking safe and effective weight loss solutions. These treatments are available directly to patients in the comfort of their homes, offices, or even hotels, making them accessible no matter the location.
The new weight loss therapies include:
Semaglutide Sublingual: A GLP-1 therapy that mimics natural hormones to regulate hunger, reduce cravings, improve blood sugar regulation, and support long-term weight management without injections.
Sermorelin Sublingual: Stimulates natural growth hormone production to enhance fat metabolism, support lean muscle growth, and improve overall vitality and sleep quality.
Advanced Weight Management Support Capsule: A combination of Naltrexone, Bupropion, Metformin, Topiramate, and Methylcobalamin that reduces cravings, boosts metabolism, and enhances insulin sensitivity for sustained weight management.
Metformin HCl ER Tablets: These sustained-release tablets regulate blood sugar levels, aid in appetite control, and support long-lasting energy.
Phentermine HCl Tablets (37.5 mg): An appetite suppressant and metabolism booster that helps control calorie intake while enhancing energy levels.
Three Convenient Delivery Options
To cater to a wide range of patient preferences, Hydreight now offers three different ways to administer these weight loss treatments:
Sublingual Drops: Allow for rapid absorption under the tongue for immediate results.
Capsules: Provide a controlled release for sustained effectiveness throughout the day.
Tablets: Offer a flexible, gradual release to ensure consistent dosing.
Telehealth Innovation for a Growing Market
Hydreight’s latest expansion comes as obesity rates rise and demand for accessible, non-invasive weight loss solutions increases. With a telehealth platform serving all 50 states, the company is uniquely positioned to provide a convenient and compliant way for patients to access treatments tailored to their needs.
CEO Shane Madden remarked, “The addition of oral weight loss therapies aligns perfectly with Hydreight’s mission to provide patient-centric healthcare. By offering nationwide, needle-free weight loss solutions through our telehealth platform, we continue to address the growing demand for accessible, effective healthcare.”
Hydreight’s platform, which includes over 3,000 licensed nurses and 100+ doctors, ensures that patients receive personalized care while adhering to strict compliance standards.
Capitalizing on the Booming Weight Loss Market
The global weight loss market is projected to exceed USD $400 billion by 2030, driven by the increasing demand for effective, non-invasive solutions. Hydreight’s scalable telehealth platform is poised to take advantage of this booming industry, offering investors exposure to a rapidly expanding market with high demand for science-backed, convenient weight loss treatments.
The company’s first-mover advantage in the telehealth weight loss space positions it for significant growth. Hydreight is well-positioned to capture a substantial share of the global weight loss market, benefiting from its comprehensive platform that delivers safe, evidence-based solutions directly to patients.
Strategic Partnerships to Expand Reach
Hydreight has also engaged GRA Enterprises LLC DBA National Inflation Association (NIA) to help increase awareness of the company’s activities. Through email distribution lists, website hosting, blog posts, and interviews, NIA will promote Hydreight’s initiatives across the U.S. The engagement will run for three months, with the possibility of extension, and NIA will receive a fee of USD $30,000 for its services.
About Hydreight Technologies
Hydreight Technologies is revolutionizing the delivery of healthcare services in the U.S. with its innovative telehealth platform. The company’s network includes over 3,000 licensed nurses and 100+ doctors across all 50 states, providing patients with convenient access to healthcare in their homes, offices, or hotels. Hydreight’s platform integrates all the necessary tools for healthcare professionals to deliver services efficiently, from accounting and documentation to inventory and patient data management.
Hydreight Technologies is also affiliated with a network of certified e-scripts and telemedicine providers, as well as a 503B pharmacy network serving all 50 states.
Related Topics:
The Impact of Gastric Band Surgery on Weight and Diabetes
